• ABT-888 (Veliparib) Experimental Workflows

  2026-09-03

  ABT-888 (Veliparib) provides a practical way to interrogate PARP1/2-dependent DNA repair and test chemo- or radiosensitization in cell and xenograft models. Its greatest value is experimental discrimination: it can reveal when PARP inhibition strengthens DNA-damaging treatments and when another damage-response pathway is the dominant determinant of response.

• Cy3 TSA Fluorescence System Kit for Cardiac IHC

  2026-09-02

  The Cy3 TSA Fluorescence System Kit converts weak HRP-linked target recognition into a bright, localized Cy3 signal for cardiac IHC, ICC, and ISH. This workflow is especially useful for mapping endothelial STING/NLRP3 activity and cardiomyocyte injury when conventional fluorescence microscopy detection is insufficient.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-09-02

  FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin conjugate for visualizing accessible α-D-glucose- and α-D-mannose-containing structures on glycoproteins and glycolipids. It supports cell surface carbohydrate detection, immunofluorescence staining, and flow cytometry, but it should not be used as a universal glycan marker or as a substitute for protein-specific antibody detection.

• AZD0156: From ATM Blockade to Metabolic Assays

  2026-09-01

  AZD0156 is a selective ATM kinase inhibitor with value beyond conventional DNA damage response studies. This article explains how ATM blockade can reshape nutrient acquisition and provides an assay framework for connecting DNA double-strand break repair with metabolic adaptation in cancer research.

• Isorhamnetin and PI3K/Akt-Driven Oocyte Maturation

  2026-09-01

  The 2024 reference study identifies Isorhamnetin as a chemical intervention that improves porcine oocyte maturation in vitro through PI3K/Akt pathway activation. Its effects are associated with lower reactive oxygen species, reduced apoptosis and endoplasmic reticulum stress, and improved mitochondrial and cellular homeostasis, although translation beyond the experimental model requires further validation.

• Deferasirox and Lysosomal Iron Stress

  2026-08-31

  Deferasirox is an oral iron chelator with value beyond iron overload treatment. This article explains how the TCF25–V-ATPase–ferritinophagy pathway reshapes experimental design for studying nutrient stress, lysosomal injury, and iron-dependent cell death.

• TAI-1: RB1-Aware Assays for Mitotic Vulnerability

  2026-08-30

  TAI-1 is a potent Hec1 inhibitor for studying mitotic disruption and cancer-selective apoptosis. This article explains how RB1-deficient retinal organoid findings can improve genotype-aware assay design without confusing developmental cell-of-origin evidence with therapeutic proof.

• γH2AX DNA Damage Detection Kit Guide

  2026-08-29

  Learn how to use the γH2AX DNA Damage Detection Kit to visualize double-strand break responses in cultured cells, tissues, and high-content assays. The workflow is especially useful for comparing FLASH-RT and conventional radiation responses, tracking repair kinetics, and supporting apoptosis or genotoxicity studies.

• RCN2 Drives ESCC Metastasis and Cisplatin Resistance

  2026-08-28

  This reference study identifies RCN2 as a previously unrecognized driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance. It connects RCN2 to UBR5-dependent PPP2CA degradation and PI3K-AKT activation, providing a mechanistic rationale for targeting this axis in resistant ESCC models.

• Ashwagandha Digestion Revealed by LC–MS/MS

  2026-08-28

  A 2026 study combined simulated gastrointestinal digestion, LC–MS/MS metabolomics, and molecular networking to examine how Withania somnifera extracts and key withanolides change before absorption. Withaferin A and withanoside IV were transformed under the assay conditions, whereas withanolide A remained comparatively stable, highlighting compound- and extract-specific digestive behavior.

• Omeprazole (A2845): Practical Research Protocol

  2026-08-27

  Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, biochemical inhibition assays, and related preclinical workflows. This guide covers preparation, controls, storage, and troubleshooting; the reagent is not intended for clinical, diagnostic, or direct therapeutic use.

• Latrunculin B: Actin Workflow and Troubleshooting

  2026-08-27

  Latrunculin B enables short, controllable perturbation of actin filament assembly for imaging, cytoskeletal organization studies, and pathway-dissection assays. This guide distinguishes direct actin effects from endocytic mechanisms and provides practical dosing, timing, and troubleshooting strategies.

• 7-Ethyl-10-hydroxycamptothecin Assay Guide

  2026-08-26

  A scenario-based guide to using 7-Ethyl-10-hydroxycamptothecin in viability, proliferation, cell-cycle, and apoptosis workflows. It explains how SKU N2133 can improve assay interpretation through controlled solvent handling, mechanism-aware readouts, and documented storage and formulation requirements.

• Topotecan (SKF104864) Cancer Research Workflows

  2026-08-26

  Build more informative Topotecan experiments by connecting Topo I trapping, exposure schedule, DNA-damage readouts, and apoptosis measurements. This practical guide differentiates short-pulse, continuous-exposure, glioma, and pediatric solid-tumor workflows while addressing solubility, pH, vehicle, and assay-timing problems.

• Ibotenic Acid: Workflows for Glutamatergic Models

  2026-08-25

  Ibotenic acid is a versatile NMDA receptor agonist for linking glutamatergic signaling modulation to behavioral, biochemical, and tissue-level outcomes. This workflow-centered guide shows how to improve preparation, time-course design, assay selection, and interpretation while avoiding common toxicity-model pitfalls.

8478 records 1/566 page Next 12345 下5页 Last page